2017
DOI: 10.5114/aic.2017.66190
|View full text |Cite
|
Sign up to set email alerts
|

Transseptal balloon atrial septostomy for decompression of the left atrium during extracorporeal membrane oxygenation support as a “bridge to transplantation” in dilated cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…9,10 Ventricular distension can also occur due to abnormal bronchial collaterals and aortic insufficiency. 11,12 Early intervention in the form of left atrial decompression can potentially reverse this pathophysiology. This can be performed using multiple methods including atrial septostomy with or without stent placement, surgical vent placement, or using assist devices such as aortic balloon pump or Impella ® (Abiomed, Danvers, MA).…”
Section: Discussionmentioning
confidence: 99%
“…9,10 Ventricular distension can also occur due to abnormal bronchial collaterals and aortic insufficiency. 11,12 Early intervention in the form of left atrial decompression can potentially reverse this pathophysiology. This can be performed using multiple methods including atrial septostomy with or without stent placement, surgical vent placement, or using assist devices such as aortic balloon pump or Impella ® (Abiomed, Danvers, MA).…”
Section: Discussionmentioning
confidence: 99%
“…The current data on the incidence of LV distention in adult and pediatric VA-ECMO patients is limited and highly variable (from 1% to 68%) (1,7,8). In a retrospective review of 134 adult VA-ECMO patients, Eliet et al [2018] reported that 27 (20%) required LV unloading, while Truby et al…”
Section: Incidencementioning
confidence: 99%
“…The above strategies in adult and pediatric patients on peripheral VA-ECMO have been shown to reduce PCWP, improve pulmonary edema, reduce LA pressure, improve ECMO output and LVEF, decrease LV distention, and improve ventricular arrhythmias refractory to medical management, as detailed in Tables S1 and S2 (8,10,12,14,(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45).…”
Section: Percutaneous Transseptal Ventmentioning
confidence: 99%